Please login to the form below

Not currently logged in
Email:
Password:

The Access Partnership

This page shows the latest The Access Partnership news and features for those working in and with pharma, biotech and healthcare.

MS and cholesterol drugs picked for new UK rapid uptake push

MS and cholesterol drugs picked for new UK rapid uptake push

Accelerated Access Partnership Rapid Uptake Products. The list as released by the Department of Health and Social Care and NICE, which is co-ordinating the ACC, including comments on the rationale ... While the ACC’s first rapid uptake list is welcome

Latest news

  • Global Pricing Innovations and Partners4Access partner on market access Global Pricing Innovations and Partners4Access partner on market access

    Will collaborate on orphan drug pricing and access solutions. Global Pricing Innovations and Partners4Access have formed a strategic partnership to offer pricing and access solutions for orphan drugs. ... The common vision we share in creating innovative

  • OncoAssist becomes latest app to be classified as a medical device OncoAssist becomes latest app to be classified as a medical device

    OncoAssist is designed to save oncologists time by providing quick and easy access to prognostic tools that can help with decisions on risk stratification and clinical trial. ... The company said it was currently on the look out for partnership

  • Succinct forms market access partnership with Royal Marsden Succinct forms market access partnership with Royal Marsden

    Succinct Healthcare Communications has entered a market access partnership with London-based cancer research and treatment centre The Royal Marsden (TRM) NHS Foundation Trust. ... We are proud to have formed what we believe is a unique partnership

  • GSK and MaRS launch innovation fund

    The partnership will provide access to capitals and opportunities for early engagement with experts to guide and position technologies for successful commercialisation through licensing or start-up company creation. ... We hope that this collaboration

  • Emerging market: Brazil

    Health minister:Jose Gomes Temporao (outgoing). The system, while providing care free at the point of need and reducing inequality ensuring that lower income families had access to healthcare, caused the ... As part of the partnership GSK will provide

More from news
Approximately 0 fully matching, plus 7 partially matching documents found.

Latest Intelligence

  • Pharma deals in June 2015 Pharma deals in June 2015

    The X-BODY acquisition gives Juno access to an antibody discovery platform that allows rapid selection of fully human antibodies, even against difficult targets. ... In a rather different approach to drug delivery, Teva has entered into a partnership

  • Biosimilars: friend or foe for healthcare systems? Biosimilars: friend or foe for healthcare systems?

    White is director of global market access at the Access Partnership and can be contacted on tel: 44 208 0695252 or email him. ... Fleetwood is director of Therapy Watch at the Research Partnership and can be contacted on tel: 44 208 0695049 or email her.

  • Pharma–payer partnerships – rhetoric or reality? Pharma–payer partnerships – rhetoric or reality?

    global director at the Access Partnership, a global market access and consultancy agency. ... pascalk@access-partnership.com.

  • A new dogma in HTA assessment A new dogma in HTA assessment

    The partnership will give AstraZeneca access to pre-existing anonymised electronic health records, and the companies will jointly develop a customised research and data analysis platform. ... The partnership helped Novartis to design better studies and

More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest appointments

  • Sandoz UK promotes Tim de Gavre to country head Sandoz UK promotes Tim de Gavre to country head

    He said: “I am immensely proud to be asked to lead the Sandoz UK team. ... I look forward to working with the Sandoz team, and in partnership with the NHS to help patients access these important medicines.”.

  • Access Partnership expands its senior team Access Partnership expands its senior team

    Healthcare market access agency Access Partnership has added to its global senior team. ... The Access Partnership was launched last year by the Research Partnership. .

  • The Access Partnership hires Mike Mallinson The Access Partnership hires Mike Mallinson

    London-based  The Access Partnership, part of the The Research Partnership, has appointed Mike Mallinson as president of the market access consultancy firm. ... Our aim is for The Access Partnership to become the preferred commercial partner for

More from appointments
Approximately 1 fully matching, plus 2 partially matching documents found.

Latest from PMHub

  • Access and elimination: the future of DAAs in hepatitis C

    Published in Pharmaphorum January 2017. The dramatic improvements in safety, efficacy, tolerability and convenience from the first wave of direct-acting antivirals (DAAs) have made a substantial contribution to changing both ... The arrival of

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Lucid Group Communications Limited

WE’RE ON A MISSION To enhance patients’ lives through communication that changes behaviour and improves patient health outcomes....

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics